MBXBF (Microbix Biosystems) Cash And Cash Equivalents : $9.35 Mil (As of Jun. 2024)

View and export this data going back to . Start your Free Trial

What is Microbix Biosystems Cash And Cash Equivalents?

Microbix Biosystems's quarterly cash and cash equivalents declined from Dec. 2023 ($9.53 Mil) to Mar. 2024 ($9.51 Mil) but then stayed the same from Mar. 2024 ($9.51 Mil) to Jun. 2024 ($9.35 Mil).

Microbix Biosystems's annual cash and cash equivalents increased from Sep. 2021 ($7.88 Mil) to Sep. 2022 ($10.11 Mil) but then declined from Sep. 2022 ($10.11 Mil) to Sep. 2023 ($8.58 Mil).

Microbix Biosystems Cash And Cash Equivalents Historical Data

The historical data trend for Microbix Biosystems's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbix Biosystems Cash And Cash Equivalents Chart

Microbix Biosystems Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Cash And Cash Equivalents

Get a 7-Day Free Trial

0.07

7.88

10.11

8.58

Microbix Biosystems Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Cash And Cash Equivalents	Get a 7-Day Free Trial															10.09	8.58	9.53	9.51	9.35

Microbix Biosystems Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Microbix Biosystems (OTCPK:MBXBF) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Microbix Biosystems Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Microbix Biosystems's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Microbix Biosystems Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (OTCPK:MBXBF) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

MBX:Canada

Address

265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3

Website

https://www.microbix.com

Microbix Biosystems Inc develops biological products and technologies. The company manufactures and develops cell culture-based biological products and technologies. It has developed and acquired two technologies; Kinlytic and LumiSort. The company's operating segment includes Antigen, QAPs DxTM and Other Includes Kinlytic. It generates maximum revenue from the Antigen QAPs segment. Geographically, it derives a majority of revenue from North America.